6181. Unmasking Nonpreserved Heart Structure, Function, and Energetics in Heart Failure With Preserved Ejection Fraction With Magnetic Resonance Imaging Coupled With Exercise.6182. Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical Trial.
作者: Mohamed Abdel-Wahab.;Philipp Hartung.;Oliver Dumpies.;Danilo Obradovic.;Johannes Wilde.;Nicolas Majunke.;Peter Boekstegers.;Ralf Müller.;Melchior Seyfarth.;Marc Vorpahl.;Philipp Kiefer.;Thilo Noack.;Sergey Leontyev.;Marcus Sandri.;Johannes Rotta Detto Loria.;Mitsunobu Kitamura.;Michael Andrew Borger.;Anne-Kathrin Funkat.;Sven Hohenstein.;Steffen Desch.;David Holzhey.;Holger Thiele.; .
来源: Circulation. 2022年145卷3期170-183页
Transcatheter aortic valve replacement is an established treatment option for patients with severe symptomatic aortic stenosis and is most commonly performed through the transfemoral access route. Percutaneous access site closure can be achieved using dedicated plug-based or suture-based vascular closure device (VCD) strategies, but randomized comparative studies are scarce.
6183. Health Behavior Change Programs in Primary Care and Community Practices for Cardiovascular Disease Prevention and Risk Factor Management Among Midlife and Older Adults: A Scientific Statement From the American Heart Association.
作者: Deepika Laddu.;Jun Ma.;Jill Kaar.;Cemal Ozemek.;Raegan W Durant.;Tavis Campbell.;Jean Welsh.;Stephanie Turrise.
来源: Circulation. 2021年144卷24期e533-e549页
Cardiovascular disease predominates as the leading health burden among middle-aged and older American adults, but progress in improving cardiovascular health remains slow. Comprehensive, evidenced-based behavioral counseling interventions in primary care are a recommended first-line approach for promoting healthy behaviors and preventing poor cardiovascular disease outcomes in adults with cardiovascular risk factors. Assisting patients to adopt and achieve their health promotion goals and arranging follow-up support are critical tenets of the 5A Model for behavior counseling in primary care. These 2 steps in behavior counseling are considered essential to effectively promote meaningful and lasting behavior change for primary cardiovascular disease prevention. However, adoption and implementation of behavioral counseling interventions in clinical settings can be challenging. The purpose of this scientific statement from the American Heart Association is to guide primary health care professional efforts to offer or refer patients for behavioral counseling, beyond what can be done during brief and infrequent office visits. This scientific statement presents evidence of effective behavioral intervention programs that are feasible for adoption in primary care settings for cardiovascular disease prevention and risk management in middle-aged and older adults. Furthermore, examples are provided of resources available to facilitate the widespread adoption and implementation of behavioral intervention programs in primary care or community-based settings and practical approaches to appropriately engage and refer patients to these programs. In addition, current national models that influence translation of evidence-based behavioral counseling in primary care and community settings are described. Finally, this scientific statement highlights opportunities to enhance the delivery of equitable and preventive care that prioritizes effective behavioral counseling of patients with varying levels of cardiovascular disease risk.
6184. Identification of Functional Genetic Determinants of Cardiac Troponin T and I in a Multiethnic Population and Causal Associations With Atrial Fibrillation.
作者: Yunju Yang.;Traci M Bartz.;Michael R Brown.;Xiuqing Guo.;Nuno R Zilhão.;Stella Trompet.;Stefan Weiss.;Jie Yao.;Jennifer A Brody.;Christopher R Defilippi.;Ron C Hoogeveen.;Henry J Lin.;Vilmundur Gudnason.;Christie M Ballantyne.;Marcus Dörr.;J Wouter Jukema.;Astrid Petersmann.;Bruce M Psaty.;Jerome I Rotter.;Eric Boerwinkle.;Myriam Fornage.;Goo Jun.;Bing Yu.
来源: Circ Genom Precis Med. 2021年14卷6期e003460页
Elevated cardiac troponin levels in blood are associated with increased risk of cardiovascular diseases and mortality. Cardiac troponin levels are heritable, but their genetic architecture remains elusive.
6185. Case With Transthyretin Amyloid Cardiomyopathy Complicated With Rapidly Progressive Aortic Stenosis Possibly Caused by Amyloid Deposition in the Aortic Valve.
作者: Tomotaka Fujimoto.;Tetsuhiro Yamano.;Aya Miyagawa-Hayashino.;Hironobu Naiki.;Mitsuharu Ueda.;Masayoshi Tasaki.;Michiyo Yamano.;Kan Zen.;Satoshi Numata.;Satoaki Matoba.
来源: Circ Cardiovasc Imaging. 2021年14卷11期e013357页 6187. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
作者: Alice H Lichtenstein.;Lawrence J Appel.;Maya Vadiveloo.;Frank B Hu.;Penny M Kris-Etherton.;Casey M Rebholz.;Frank M Sacks.;Anne N Thorndike.;Linda Van Horn.;Judith Wylie-Rosett.
来源: Circulation. 2021年144卷23期e472-e487页
Poor diet quality is strongly associated with elevated risk of cardiovascular disease morbidity and mortality. This scientific statement emphasizes the importance of dietary patterns beyond individual foods or nutrients, underscores the critical role of nutrition early in life, presents elements of heart-healthy dietary patterns, and highlights structural challenges that impede adherence to heart-healthy dietary patterns. Evidence-based dietary pattern guidance to promote cardiometabolic health includes the following: (1) adjust energy intake and expenditure to achieve and maintain a healthy body weight; (2) eat plenty and a variety of fruits and vegetables; (3) choose whole grain foods and products; (4) choose healthy sources of protein (mostly plants; regular intake of fish and seafood; low-fat or fat-free dairy products; and if meat or poultry is desired, choose lean cuts and unprocessed forms); (5) use liquid plant oils rather than tropical oils and partially hydrogenated fats; (6) choose minimally processed foods instead of ultra-processed foods; (7) minimize the intake of beverages and foods with added sugars; (8) choose and prepare foods with little or no salt; (9) if you do not drink alcohol, do not start; if you choose to drink alcohol, limit intake; and (10) adhere to this guidance regardless of where food is prepared or consumed. Challenges that impede adherence to heart-healthy dietary patterns include targeted marketing of unhealthy foods, neighborhood segregation, food and nutrition insecurity, and structural racism. Creating an environment that facilitates, rather than impedes, adherence to heart-healthy dietary patterns among all individuals is a public health imperative.
6188. Optimal Methods for Reducing Proxy-Introduced Bias on Patient-Reported Outcome Measurements for Group-Level Analyses.
作者: Brittany Lapin.;Nicolas Thompson.;Andrew Schuster.;Irene L Katzan.
来源: Circ Cardiovasc Qual Outcomes. 2021年14卷11期e007960页
Caregivers, or proxies, often complete patient-reported outcomes (PROs) on behalf of patients; yet, research has demonstrated proxies rate patient outcomes worse than patients rate their own outcomes. To improve interpretability of PROs in group-level analyses, our study aimed to identify optimal approaches for reducing proxy-introduced bias in the analysis of PROs.
6189. Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration.
作者: Alexander C Perino.;Jun Fan.;Susan Schmitt.;Jennifer D Guo.;Patrick Hlavacek.;Natasha Din.;Mitra Kothari.;Krishna Pundi.;Cristina Russ.;Birol Emir.;Mintu P Turakhia.
来源: Circ Cardiovasc Qual Outcomes. 2021年14卷11期e008005页
Consensus statements have recommended against the use of direct oral anticoagulants (DOACs) in venous thromboembolism (VTE) for patients ≥120 kg and ≥40 kg/m2. We sought to determine use and outcomes of DOACs for VTE across weight and body mass index (BMI).
6193. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis.
作者: John R Power.;Joachim Alexandre.;Arrush Choudhary.;Benay Ozbay.;Salim Hayek.;Aarti Asnani.;Yuichi Tamura.;Mandar Aras.;Jennifer Cautela.;Franck Thuny.;Lauren Gilstrap.;Dimitri Arangalage.;Steven Ewer.;Shi Huang.;Anita Deswal.;Nicolas L Palaskas.;Daniel Finke.;Lorenz Lehman.;Stephane Ederhy.;Javid Moslehi.;Joe-Elie Salem.; .
来源: Circulation. 2021年144卷18期1521-1523页 6198. Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association.
作者: Elizabeth M McNally.;Mitchell S V Elkind.;Ivor J Benjamin.;Mina K Chung.;Glenn H Dillon.;Adrian F Hernandez.;Chinwe Ibeh.;Donald M Lloyd-Jones.;Louise D McCullough.;Loren E Wold.;Davene R Wright.;Joseph C Wu.
来源: Circulation. 2021年144卷23期e461-e471页
The coronavirus disease 2019 (COVID-19) pandemic has had worldwide repercussions for health care and research. In spring 2020, most non-COVID-19 research was halted, hindering research across the spectrum from laboratory-based experimental science to clinical research. Through the second half of 2020 and the first half of 2021, biomedical research, including cardiovascular science, only gradually restarted, with many restrictions on onsite activities, limited clinical research participation, and the challenges associated with working from home and caregiver responsibilities. Compounding these impediments, much of the global biomedical research infrastructure was redirected toward vaccine testing and deployment. This redirection of supply chains, personnel, and equipment has additionally hampered restoration of normal research activity. Transition to virtual interactions offset some of these limitations but did not adequately replace the need for scientific exchange and collaboration. Here, we outline key steps to reinvigorate biomedical research, including a call for increased support from the National Institutes of Health. We also call on academic institutions, publishers, reviewers, and supervisors to consider the impact of COVID-19 when assessing productivity, recognizing that the pandemic did not affect all equally. We identify trainees and junior investigators, especially those with caregiving roles, as most at risk of being lost from the biomedical workforce and identify steps to reduce the loss of these key investigators. Although the global pandemic highlighted the power of biomedical science to define, treat, and protect against threats to human health, significant investment in the biomedical workforce is required to maintain and promote well-being.
6199. Understanding Circadian Mechanisms of Sudden Cardiac Death: A Report From the National Heart, Lung, and Blood Institute Workshop, Part 2: Population and Clinical Considerations.
作者: Brian P Delisle.;Alfred L George.;Jeanne M Nerbonne.;Joseph T Bass.;Crystal M Ripplinger.;Mukesh K Jain.;Tracey O Hermanstyne.;Martin E Young.;Prince J Kannankeril.;Jeanne F Duffy.;Joshua I Goldhaber.;Martica H Hall.;Virend K Somers.;Michael H Smolensky.;Christine E Garnett.;Ron C Anafi.;Frank A J L Scheer.;Kalyanam Shivkumar.;Steven A Shea.;Ravi C Balijepalli.
来源: Circ Arrhythm Electrophysiol. 2021年14卷11期e010190页
Sudden cardiac death (SCD) is the sudden, unexpected death due to abrupt loss of heart function secondary to cardiovascular disease. In certain populations living with cardiovascular disease, SCD follows a distinct 24-hour pattern in occurrence, suggesting day/night rhythms in behavior, the environment, and endogenous circadian rhythms result in daily spans of increased vulnerability. The National Heart, Lung, and Blood Institute convened a workshop, Understanding Circadian Mechanisms of Sudden Cardiac Death to identify fundamental questions regarding the role of the circadian rhythms in SCD. Part 2 summarizes research gaps and opportunities in the areas of population and clinical research identified in the workshop. Established research supports a complex interaction between circadian rhythms and physiological responses that increase the risk for SCD. Moreover, these physiological responses themselves are influenced by several biological variables, including the type of cardiovascular disease, sex, age, and genetics, as well as environmental factors. The emergence of new noninvasive biotechnological tools that continuously measure key cardiovascular variables, as well as the identification of biomarkers to assess circadian rhythms, hold promise for generating large-scale human data sets that will delineate which subsets of individuals are most vulnerable to SCD. Additionally, these data will improve our understanding of how people who suffer from circadian disruptions develop cardiovascular diseases that increase the risk for SCD. Emerging strategies to identify new biomarkers that can quantify circadian health (eg, environmental, behavioral, and internal misalignment) may lead to new interventions and therapeutic targets to prevent the progression of cardiovascular diseases that cause SCD.
6200. Understanding Circadian Mechanisms of Sudden Cardiac Death: A Report From the National Heart, Lung, and Blood Institute Workshop, Part 1: Basic and Translational Aspects.
作者: Brian P Delisle.;Alfred L George.;Jeanne M Nerbonne.;Joseph T Bass.;Crystal M Ripplinger.;Mukesh K Jain.;Tracey O Hermanstyne.;Martin E Young.;Prince J Kannankeril.;Jeanne F Duffy.;Joshua I Goldhaber.;Martica H Hall.;Virend K Somers.;Michael H Smolensky.;Christine E Garnett.;Ron C Anafi.;Frank A J L Scheer.;Kalyanam Shivkumar.;Steven A Shea.;Ravi C Balijepalli.
来源: Circ Arrhythm Electrophysiol. 2021年14卷11期e010181页
Sudden cardiac death (SCD), the unexpected death due to acquired or genetic cardiovascular disease, follows distinct 24-hour patterns in occurrence. These 24-hour patterns likely reflect daily changes in arrhythmogenic triggers and the myocardial substrate caused by day/night rhythms in behavior, the environment, and endogenous circadian mechanisms. To better address fundamental questions regarding the circadian mechanisms, the National Heart, Lung, and Blood Institute convened a workshop, Understanding Circadian Mechanisms of Sudden Cardiac Death. We present a 2-part report of findings from this workshop. Part 1 summarizes the workshop and serves to identify research gaps and opportunities in the areas of basic and translational research. Among the gaps was the lack of standardization in animal studies for reporting environmental conditions (eg, timing of experiments relative to the light dark cycle or animal housing temperatures) that can impair rigor and reproducibility. Workshop participants also pointed to uncertainty regarding the importance of maintaining normal circadian rhythmic synchrony and the potential pathological impact of desynchrony on SCD risk. One related question raised was whether circadian mechanisms can be targeted to reduce SCD risk. Finally, the experts underscored the need for studies aimed at determining the physiological importance of circadian clocks in the many different cell types important to normal heart function and SCD. Addressing these gaps could lead to new therapeutic approaches/molecular targets that can mitigate the risk of SCD not only at certain times but over the entire 24-hour period.
|